NCT00171886 - Octreotide Efficacy and Safety in First-line Acromegalic Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2002

Primary Completion Date

May 31, 2006

Study Completion Date

May 31, 2006

Conditions

Acromegaly

Interventions

DRUG

Octreotide

Trial Locations (8)

Novartis Investigative site, A Coruña

Novartis Investigative site, Alicante

Novartis Investigative site, Barcelona

Novartis Investigative site, Burgos

Novartis Investigative site, Córdoba

Novartis Investigative site, Madrid

Novartis Investigative site, Málaga

Novartis Investigative site, Tarragona